Gynov Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$573K
- Investors
-
1
Gynov General Information
Description
Developer of nutritional supplements designed to serve women's health. The company is involved in the scientific application of dietary supplements, using carefully selected ingredients through a multi-target, holistic approach, enabling women to access scientifically researched products during puberty, pregnancy, the postpartum period, and the peri- and post-menopause periods.
Contact Information
Website
www.gynov.comCorporate Office
- 2 Rue Sauteyron
- 33000 Bordeaux
- France
Corporate Office
- 2 Rue Sauteyron
- 33000 Bordeaux
- France
Gynov Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 26-Nov-2021 | $573K | Completed | Generating Revenue |
Gynov Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Gynov Patents
Gynov Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3177937-A1 | Compositions and combinations for subjects suffering from endometriosis | Pending | 19-May-2020 | ||
| EP-4153203-A1 | Compositions and combinations for subjects suffering from endometriosis | Active | 19-May-2020 | ||
| EP-4153203-B1 | Compositions and combinations for subjects suffering from endometriosis | Active | 19-May-2020 | ||
| EP-4153203-C0 | Compositions and combinations for subjects suffering from endometriosis | Active | 19-May-2020 | ||
| ES-3013129-T3 | Compositions and combinations for subjects suffering from endometriosis | Active | 19-May-2020 | A61K36/064 |
Gynov Signals
Gynov Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eure Kare | VC-Backed Company | Minority |
Gynov FAQs
-
When was Gynov founded?
Gynov was founded in 2016.
-
Where is Gynov headquartered?
Gynov is headquartered in Bordeaux, France.
-
What is the size of Gynov?
Gynov has 7 total employees.
-
What industry is Gynov in?
Gynov’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Gynov a private or public company?
Gynov is a Private company.
-
What is the current valuation of Gynov?
The current valuation of Gynov is .
-
What is Gynov’s current revenue?
The current revenue for Gynov is .
-
How much funding has Gynov raised over time?
Gynov has raised $573K.
-
Who are Gynov’s investors?
Eure Kare has invested in Gynov.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process